Statistics for Standard BioTools (id:8299 LAB)

Valuation metrics

Market cap

588.17M

Enterprise value

204.31M

Trailing P/E (ttm)

-1.71

Forward P/E

-7.18

PEG ratio

-7.18

Price/Sales (ttm)

3.77

Price/Book (mrq)

1.28

Enterprise Value/Revenue

1.31

Enterprise Value/EBITDA

-1.79

Overview

Shares outstanding

372.26M

Float

48.84M

Shares short

19.54M

% Held by insiders

0.02%

% Held by institutions

0.73%

Average volume (10 days)

2.46M

Average volume (90 days)

Price summary

52-Week low

1.21

52-Week high

3.04

52-Week change

-51.55%

Beta

1.57

50-Day moving average

1.92

200-Day moving average

2.21

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-79.92%

Operating margin

-29.42%

Operational effectiveness

Return on assets

-14.68%

Return on equity

-37.25%

Income statement

Revenue (ttm)

0.56

Revenue per share (ttm)

0.56

Quarterly revenue growth (yoy)

Gross profit (ttm)

50.45M

EBITDA

-114,313,000.00

Net income to common (ttm)

-170,603,008.00

Diluted EPS (ttm)

-0.69

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

28.45M

Total cash per share (mrq)

0.37

Total debt (mrq)

111.65M

Total Debt/Equity (mrq)

118.03

Current ratio (mrq)

376.10%

Book value per share (mrq)

1.23

Cash flow

Cash flow statement

-143,456,000.00

Levered free cash flow (LFCF)

-66,162,752.00